Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H14N6S2.Cu |
Molecular Weight | 322.297 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 4 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[64Cu++].CN\C([S-])=N\N=C(C)\C(C)=N\N=C(/[S-])NC
InChI
InChIKey=SBHDKYTVDCRMOE-NLRRAJSESA-L
InChI=1S/C8H16N6S2.Cu/c1-5(11-13-7(15)9-3)6(2)12-14-8(16)10-4;/h1-4H3,(H2,9,13,15)(H2,10,14,16);/q;+2/p-2/b11-5+,12-6+;/i;1+0
CNS Activity
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats. | 1999 Jan |
|
Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research. | 2009 Aug |
|
Pre-clinical Positron Emission Tomography Reconstruction Algorithm Effect on Cu-64 ATSM Lesion Hypoxia. | 2016 Feb 5 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18552145/
In a clinical study, ATSM CU-64 was intravenously injected as a single dose of 925 MBq.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9935074
EMT6 Cells were equilibrated and 7.4 MBq (200 uCi) (0.15 ug) ATSM CU-64 were added. The percentage of uptake was 80% after 1 h.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
213531-97-6
Created by
admin on Fri Dec 15 17:06:02 GMT 2023 , Edited by admin on Fri Dec 15 17:06:02 GMT 2023
|
PRIMARY | |||
|
91668168
Created by
admin on Fri Dec 15 17:06:02 GMT 2023 , Edited by admin on Fri Dec 15 17:06:02 GMT 2023
|
PRIMARY | |||
|
SW5KMQ68KN
Created by
admin on Fri Dec 15 17:06:02 GMT 2023 , Edited by admin on Fri Dec 15 17:06:02 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD